Illumanations: The Future of Healthcare

In this episode, Dr. Themasap Khan sits down with Aeovian Pharmaceuticals' Presidentand CEO, Dr. Allison Hulme to discuss how she found herself in the pharmaspace, what's ahead for Aeovian, and why the work they are doing is soimportant for a population with an incredibly high unmet need. We are alsoexcited to welcome Aeovian and the full team to Luma Group as our most recentinvestment (December 2025).

On this episode of IlLUMAnations, we turned inwards for the first time. Co-Founder and Partner of Luma Group, Themasap Khan, PhD, sits down with Neel Madhukar, PhD, Chief Technology Officer of Luma Group’s proprietary AI model, LABI, to discuss the genesis of the program and how it impacts day-to-day processes at Luma Group. Neel and Themasap discuss what we are building at Luma Group to change the game for biotech investing. LABI enables our investors to run deeper and more complex diligence processes, while simultaneously speeding up the process. Neel explains that LABI is an agentic system and therefore able to pull data, graphs, and research while connecting the concepts, allowing our investors to access all the information they need for diligence in minutes.

In our latest episode of IlLUMAnations, Dr. Themasap Khan, co-founder and partner, sat down with Ritish Patnaik, CEO and co-founder of Curve Biosciences, to discuss his career, the journey to co-founding Curve, the company’s transformative impact, and what’s next. Beyond delving into Curve’s groundbreaking science, Ritish shares leadership insights and advice for navigating the world of biotech, explaining how his life experience pushed him to biotech.

In this episode, Dr. Jamie Kasuboski sits down with Character Biosciences' co-founder and CEO, Cheng Zhang about his career, the journey to co-founding Character Bio and the company’s transformative impact. Cheng also shares leadership insights and advice for navigating the world of biotech.

In this episode, Hans Bishop, President, Founder, and Board Co-Chair of Altos Labs, discusses the transformative potential of early cancer detection, the importance of assembling the right team and the evolving landscape of biotech innovations. With over 30 years of experience in the biotechnology industry, Hans shares insights into the future of medicine, the challenges of drug development and the exciting possibilities that lie ahead.

Dr. Kapeller speaks with Dr. Themasap Khan, PhD and Luma Group Co-Founder, about her path to the biotech industry and leading the development of new approaches to treating serious diseases to unlock the power of the ‘dark genome.’